BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34245687)

  • 1. Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.
    Bogdanos DP; Gkoutzourelas A; Papadopoulos V; Liaskos C; Patrikiou E; Tsigalou C; Saratziotis A; Hajiioannou J; Scheper T; Meyer W; Sakkas LI; Papandreou C
    Clin Chim Acta; 2021 Oct; 521():199-205. PubMed ID: 34245687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of antigen-specific anti-cytomegalovirus antibody reactivity in patients with systemic sclerosis and concomitant anti-Ro52 antibodies.
    Gkoutzourelas A; Liaskos C; Simopoulou T; Katsiari C; Efthymiou G; Scheper T; Meyer W; Tsirogianni A; Tsigalou C; Dardiotis E; Daoussis D; Sakkas LI; Bogdanos DP
    Rheumatol Int; 2020 Oct; 40(10):1689-1699. PubMed ID: 32681396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
    Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Front Immunol; 2018; 9():2835. PubMed ID: 30581434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.
    Chan EKL
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):178-193. PubMed ID: 35040083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
    Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
    Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
    Front Immunol; 2018; 9():1200. PubMed ID: 29922285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
    Murng SHK; Thomas M
    J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
    Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
    J Immunol; 2006 May; 176(10):6277-85. PubMed ID: 16670339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid serological detection of autoantibodies associated with Sjögren's syndrome.
    Burbelo PD; Ching KH; Issa AT; Loftus CM; Li Y; Satoh M; Reeves WH; Iadarola MJ
    J Transl Med; 2009 Sep; 7():83. PubMed ID: 19778440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of the clinical significance of Ro52/TRIM21 antibody and specific antinuclear antibody patterns by indirect immunofluorescence.
    Liu K; Liao Y; Li P; Shi J
    J Pak Med Assoc; 2024 Feb; 74(2):236-242. PubMed ID: 38419219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
    Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
    Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological epitope profile of anti-Ro52-positive patients with systemic autoimmune rheumatic diseases.
    Infantino M; Meacci F; Grossi V; Benucci M; Morozzi G; Tonutti E; Tampoia M; Ott A; Meyer W; Atzeni F; Sarzi-Puttini P; Manfredi M; Bizzaro N
    Arthritis Res Ther; 2015 Dec; 17():365. PubMed ID: 26673754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
    Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
    Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping with synthetic peptides of 52-kD SSA/Ro protein reveals heterogeneous antibody profiles in human autoimmune sera.
    Ricchiuti V; Briand JP; Meyer O; Isenberg DA; Pruijn G; Muller S
    Clin Exp Immunol; 1994 Mar; 95(3):397-407. PubMed ID: 7511075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of anti-Ro52 detection in systemic autoimmunity.
    Dugar M; Cox S; Limaye V; Gordon TP; Roberts-Thomson PJ
    Postgrad Med J; 2010 Feb; 86(1012):79-82. PubMed ID: 20145055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.
    Bozic B; Pruijn GJ; Rozman B; van Venrooij WJ
    Clin Exp Immunol; 1993 Nov; 94(2):227-35. PubMed ID: 7693382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
    Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
    Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Sjögren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production.
    Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Dec; 194(3):315-326. PubMed ID: 30178506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.